CPT Camden Property Trust
$98.03
▼ 0.2%Updated Oct 16, 2:25 PM ET
Report Card
CPT at a glance — five pillars scored 0–100 from real filed financials.
How the 0–100 rating is calculatedOverall: Favorable · 59/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
Price — Past Year
▼ Down 5.7% in the year to Jul 6, 2026
Key Metrics
Market Cap
$15.85B
P/E
34.16x
Forward P/E (est.)
24.4x
ROE
8.9%
Revenue Growth
1.3%
EPS Growth
229.7%
Profit Margin
24.7%
FCF Yield
6.6%
Debt / Equity
0.89x
ROIC
—
Interest Coverage
—
Current Ratio
—
Dividend Yield
3.7%
Implied Growth (rev. DCF)
—
Rating Score
59/100
Business Overview
Camden Property Trust (CPT) is a large-cap company in the Multi-Family Residential REITs industry, part of the Real Estate sector of the S&P 500, with a market value around $15.85B.
In its latest reported year it generated about $12.97M in revenue and $384.46M in net profit.
Our model rates CPT Favorable (59/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Technical Analysis (Educational)
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what CPT's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. CPT trades near $98.03, below its 50-day average ($108.39) and 200-day average ($105.71). Price below both averages is a downtrend — momentum is against buyers for now.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 57 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. CPT's is $2.37 (~2.4% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. In the month to Jul 6, 2026, CPT found buyers near $107.97 (support) and sellers near $117.56 (resistance); its 52-week range then was $96.53–$117.56. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.6× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. The indicators were last computed on Jul 6, 2026; the price is current.
Revenue Growth
4Y CAGR
5.3%
Revenue moved from $876.45M in 2016 to $12.97M in 2025, a -37.4% compound annual growth rate. The most recent year was roughly flat (1.3%) year over year. Slower, mature growth is common for established businesses.
Profitability
Gross Margin
61.3%
Operating Margin
4.7%
Net Margin
2964.9%
ROE
8.9%
Camden Property Trust keeps about 24.7% of each sales dollar as net profit, with a 61.3% gross margin and 4.7% operating margin. Return on equity is 8.9%. Margins this wide usually signal pricing power or a cost advantage.
Debt Analysis
Total Debt
$4.85B
Net Debt
$4.80B
Net Debt / EBITDA
—
Debt / Equity
0.89x
Leverage: debt-to-equity is 0.9x. That is a moderate, manageable debt load for most businesses. It carries roughly $4.85B of total debt against $44.72M of cash.
Cash Flow Analysis
Operating CF
$826.62M
Free Cash Flow
$826.62M
FCF Margin
6374.8%
In the latest year Camden Property Trust produced about $826.62M of operating cash flow and $826.62M of free cash flow after capital spending. That is a free-cash-flow yield of about 6.6% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.
Dividend Safety
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
What to look for in a dividend stockThe dividend is being paid, but coverage or consistency is thinner than an income investor should rely on without a closer look.
Dividend yield
3.7%
Per share (latest FY)
$4.20
Total paid (latest FY)
$460.95M
History on record
10 years
dividend uses 56% of free cash flow
120% of net income paid out
total dividends increased 8 years in a row
payout was cut at least once in the last 10 years
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
Valuation Analysis
P/E
34.16x
P/S
9.66x
P/B
3.12x
EV / EBITDA
—
CPT trades at 34.2x trailing earnings (about 24.4x on estimated forward earnings), 9.7x sales, and 3.1x book value. That is a premium multiple that needs growth to justify it.
Metrics vs. Sector Range
Where CPT sits versus the Real Estate companies we cover.
Bands show the middle half (25th–75th percentile) of the 33 Real Estate companies in our coverage that have fundamentals data — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
Sector Peer Comparison
How CPT stacks up against its Real Estate peers — valuation, profitability, and growth versus the sector median.
Among the 33 rated Real Estate companies we cover, CPT ranks #9 by our overall rating. It trades at roughly in line versus the sector on earnings (34.2x P/E vs. 29.9x median) with a higher return on equity (8.9% vs. 8.0%) and slower revenue growth (1.3% vs. 5.3%).
P/E vs sector
34.2x
median 29.9x
ROE vs sector
8.9%
median 8.0%
Growth vs sector
1.3%
median 5.3%
Sector rank
#9
of 33 rated
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Real Estate companies by sub-industry and size, preferring ones with full data. Sector medians and rank use the 33 rated companies among the 41 Real Estate stocks we cover. Educational, not a recommendation.
5-Year Projection Model
Project revenue → earnings → price. Edit the assumptions to build your own case.
What drives this projection, and its limits2030 scenario price range (Base Case)
$0.93 – $1.58
vs. $98.03 today · implied CAGR -61% – -56%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $13.36M | $13.76M | $14.17M | $14.59M | $15.03M |
| Net income | $6.68M | $6.88M | $7.08M | $7.30M | $7.52M |
| EPS | $0.04 | $0.04 | $0.04 | $0.05 | $0.05 |
| Share price (low) | $0.83 | $0.85 | $0.88 | $0.90 | $0.93 |
| Share price (high) | $1.40 | $1.45 | $1.49 | $1.53 | $1.58 |
| CAGR (low–high) | -99% / -99% | -91% / -88% | -79% / -75% | -69% / -65% | -61% / -56% |
Educational scenario model, not a forecast or investment advice. It starts from the latest annual revenue in SEC filings. By default, growth is trailing revenue growth (held between 3% and 45% a year), the net margin is the latest one (held between 3% and 50%, so a loss-making company is modeled with a small profit), and the Base case P/E runs from 60% to 100% of today's. Carrying recent growth forward five years can miss badly in either direction. Outputs are only as good as the assumptions.
Bull Case
The case for CPT:
- High net margins (24.7%) point to pricing power or efficiency.
- Healthy free-cash-flow yield (~6.6%) funds buybacks and dividends.
- Pays a 3.7% dividend on top of any price gains.
- Our model's overall read is Favorable (59/100).
Bear Case
The case against CPT:
- Revenue growth is slow (1.3%), limiting the upside engine.
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Key Risks
Valuation risk — at 34.2x earnings, disappointing results could compress the multiple.
Growth risk — sluggish revenue (1.3%) leaves little margin for execution missteps.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
Investment Thesis
On balance, the fundamentals screen favourably: Camden Property Trust is a large-cap real estate business growing at a mature pace, with solid profitability, and a heavier debt load to watch. It trades at 34.2x earnings, which our model scores Favorable (59/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 29 Wall Street analysts covering CPT recommend (September 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Analysts have turned more cautious over the last three months (-3 pts of buy ratings).
Latest SEC Filings
CPT's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen. How to read a 10-K
In the Idea Lab
CPT — frequently asked questions
Is CPT a good stock to buy?
We don't give buy or sell advice. Our model rates Camden Property Trust Favorable (59/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is CPT's rating on The Stocks School?
Camden Property Trust currently scores 59/100 (Favorable) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does CPT's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Camden Property Trust's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for CPT calculated?
It's a scenario model. It starts from the latest annual revenue and net margin in SEC filings, grows revenue at an assumed rate (trailing revenue growth by default), and applies a P/E range built around today's multiple to show the resulting share-price range. When a stock has no growth or P/E data, the starting values are placeholders. It's a tool for thinking, not a prediction.
Is this CPT analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell CPT. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.